• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[口服粉剂组合中奥美拉唑、碳酸氢钠和海藻酸的抑酸能力]

[Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].

作者信息

Soifer Luis, Peralta Angel Daniel, Arenoso Héctor, Caruso Norberto, Naisberg Gabriela

机构信息

UNIMOT (Unidad de Motilidad y Patología Funcional Digestiva) - CABA, Argentina.

出版信息

Acta Gastroenterol Latinoam. 2009 Dec;39(4):261-6.

PMID:20178255
Abstract

BACKGROUND

The combination of omeprazole, sodium bicarbonate and alginic acid protects omeprazole from acid degradation and enhances the speed of action of the proton pump inhibitors.

AIM

To assess acid suppression capacity and speed of action of an oral powder combination (omeprazole 20 mg, sodium bicarbonate 1680 mg and alginic acid 250.08 mg) in healthy subjects, using gastric 24 h pHmetry.

SUBJECTS AND METHODS

Gastric 24 h pHmetry was performed in 13 healthy subjects on days 0 and 6. During the first pHmetry, 7 subjects received the combination 2 h before the end of the procedure. The second study was performed after the subjects had been administered the medication for the six previous days. The measurements were: a) time with pH < 4, b) time to reach maximum pH value, and c) pH peak after first drug administration.

RESULTS

The percentage of time with pH < 4 was 72.02 +/- 20.18 in the first study and 34.05 +/- 20.50 in the second (p < 0.01). Maximum pH obtained after first drug administration was 6.98 +/- 1.66 and the time to reach the pH peak was 18.34 +/- 9.84 minutes.

CONCLUSION

This oral powder combination induces significant, fast and intensive gastric acid suppression. Unlike delayed-release proton pump inhibitors, this product provides a faster but equally sustained control of gastric acidity.

摘要

背景

奥美拉唑、碳酸氢钠和海藻酸的组合可保护奥美拉唑不被胃酸降解,并提高质子泵抑制剂的起效速度。

目的

通过24小时胃pH监测,评估一种口服粉剂组合(奥美拉唑20毫克、碳酸氢钠1680毫克和海藻酸250.08毫克)在健康受试者中的抑酸能力和起效速度。

受试者与方法

在第0天和第6天对13名健康受试者进行24小时胃pH监测。在第一次pH监测期间,7名受试者在检查结束前2小时服用该组合药物。第二次研究在受试者连续服用该药物六天后进行。测量指标包括:a)pH值<4的时间;b)达到最大pH值的时间;c)首次给药后的pH峰值。

结果

在第一项研究中,pH值<4的时间百分比为72.02±20.18,在第二项研究中为34.05±20.50(p<0.01)。首次给药后获得的最大pH值为6.98±1.66,达到pH峰值的时间为18.34±9.84分钟。

结论

这种口服粉剂组合可引起显著、快速且强烈的胃酸抑制。与缓释质子泵抑制剂不同,该产品能更快且同样持久地控制胃酸度。

相似文献

1
[Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].[口服粉剂组合中奥美拉唑、碳酸氢钠和海藻酸的抑酸能力]
Acta Gastroenterol Latinoam. 2009 Dec;39(4):261-6.
2
Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.奥美拉唑钠碳酸氢钠(CDFR0209)联合与单独使用延迟释放奥美拉唑 40mg 在健康成年男性受试者中的抑酸效果比较。
Clin Pharmacol Drug Dev. 2018 Jan;7(1):53-58. doi: 10.1002/cpdd.331. Epub 2017 Jan 23.
3
[Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].[新型口服粉末状奥美拉唑混悬液对胃食管反流病婴儿胃酸的抑制作用。一项初步研究]
Acta Gastroenterol Latinoam. 2011 Jun;41(2):111-8.
4
Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.口服混悬液型速释奥美拉唑与泮托拉唑缓释片对有症状的胃食管反流病患者夜间酸突破影响的比较
Aliment Pharmacol Ther. 2005 Jun 15;21(12):1467-74. doi: 10.1111/j.1365-2036.2005.02513.x.
5
Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05.奥美拉唑/抗酸剂粉末混悬液-桑塔鲁斯公司:奥美拉唑/碳酸氢钠粉末-桑塔鲁斯公司,产品编号SAN 05。
Drugs R D. 2004;5(6):349-50. doi: 10.2165/00126839-200405060-00007.
6
Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.奥美拉唑-碳酸氢钠钠治疗巴雷特食管患者的食管内 pH 控制。
Aliment Pharmacol Ther. 2012 Apr;35(7):803-9. doi: 10.1111/j.1365-2036.2012.05016.x. Epub 2012 Feb 22.
7
Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.组胺2受体拮抗剂与质子泵抑制剂联合使用可增强胃酸抑制作用。
Pharmacotherapy. 2015 Dec;35(12):1124-9. doi: 10.1002/phar.1665. Epub 2015 Dec 1.
8
Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.采用即释型和缓释型质子泵抑制剂晨起给药控制胃食管反流病患者24小时胃内酸度
J Clin Gastroenterol. 2009 Apr;43(4):323-6. doi: 10.1097/MCG.0b013e31818a386e.
9
Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.奥美拉唑-碳酸氢钠口服混悬液部分剂量的稳定性
Ann Pharmacother. 2007 Dec;41(12):1954-61. doi: 10.1345/aph.1K246. Epub 2007 Oct 23.
10
Efficacy of omeprazole/sodium bicarbonate treatment in gastroesophageal reflux disease: a systematic review.奥美拉唑/碳酸氢钠治疗胃食管反流病的疗效:一项系统评价
Medwave. 2018 Mar 14;18(2):e7179. doi: 10.5867/medwave.2018.02.7179.